Haiyi Jiang
Institut Gustave Roussy
2 papers in the Anchorcite directory, published between 2009 and 2017, cited 13,070 times in total.
ORCID profileResearch topics
- Lung Cancer Diagnosis and Treatment · 2 papers
- Lung Cancer Treatments and Mutations · 2 papers
- Lung Cancer Research Studies · 1 paper
- Cancer Immunotherapy and Biomarkers · 1 paper
Frequent co-authors
- Tony S.K. Mok · 1 paper
- Yi-Long Lung Cancer Wu · 1 paper
- Sumitra Thongprasert · 1 paper
- Da-Tong Chu · 1 paper
- Nagahiro Saijo · 1 paper
- Patrapim Sunpaweravong · 1 paper
- Baohui Han · 1 paper
- Benjamin Palgunadi Margono · 1 paper
Papers
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine · 2009 · 8,355 citations
BACKGROUND: Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in selected patients with non-small-cell lung cancer. METHODS: In this phase 3, open-label study, we randomly assigned previously untreated patients in East Asia who had advanced…
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerNew England Journal of Medicine · 2017 · 4,715 citations
BACKGROUND: Most patients with locally advanced, unresectable, non-small-cell lung cancer (NSCLC) have disease progression despite definitive chemoradiotherapy (chemotherapy plus concurrent radiation therapy). This phase 3 study compared the anti-programmed death ligand 1 antibody durvalumab as consolidation therapy with placebo in…
Metadata from OpenAlex (CC0).